Around 75 medication applicants dependent on synlet quality sets are being assessed for the therapy of different kinds of diseases; by and by, there are more than 20 screening stages empowering treatment improvement endeavors.

Written by

To order this 485+ page report, which features 195+ figures and 200+ tables, please visit https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market/267.html

 

The USD 8 billion (by 2030) financial opportunity within the synthetic lethality-based drugs and targets market has been analyzed across the following segments:

  • Type of molecule
  • Small Molecule
  • Biologic

 

  • Target disease indication
  • Breast Cancer
  • Colorectal Cancer
  • Fallopian Tube Cancer
  • Gastric Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Ovarian Cancer
  • Peritoneal Cancer
  • Others

 

  • Type of synlet target
  • APE1 / Ref-1
  • Chk1
  • GLS1
  • PARP
  • Pol θ
  • PP2A
  • Wee1

 

  • Route of administration
  • Oral
  • Intravenous

 

  • Key geographical regions
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

 

The https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html, report features the following companies, which we identified to be key players in this domain:

  • AbbVie
  • AstraZeneca
  • AtlasMedx
  • BeiGene
  • Chordia Therapeutics
  • Clovis Oncology
  • GlaxoSmithKline
  • IDEAYA Biosciences
  • Mission Therapeutics
  • Pfizer
  • Repare Therapeutics
  • Sierra Oncology
  • SyntheX Labs

 

Table of Contents

 

  1. Preface

    2. Executive Summary

  2. Introduction to DNA Damage and Repair Systems
  3. Introduction to Synthetic Lethality
  4. Market Overview
  5. Company Profiles
  6. Emerging Trends on Social Media
  7. Publication Analysis
  8. Abstract Analysis
  9. Academic Grants Analysis
  10. Funding and Investment Analysis
  11. Target Benchmark Analysis

 

  1. Role of Companion Diagnostics in Synthetic Lethality

 

  1. Market Forecast
  2. Concluding Remarks
  3. Executive Insights

 

  1. Appendix 1: Tabulated Data

 

  1. Appendix 2: List of Companies and Organizations

 

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

Facebook – https://www.facebook.com/RootsAnalysis

LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter – https://twitter.com/RootsAnalysis

Medium – https://medium.com/@RootsAnalysis

Pinterest – https://in.pinterest.com/RootsanalysisPin/_saved/

Quora – https://rootsanalysisinsights.quora.com/

Article Categories:
Health

Leave a Reply

Your email address will not be published. Required fields are marked *